Showing 1 - 10 of 12
Cost-effectiveness analysis has been advocated in the health economics methods literature and adopted in a growing number of jurisdictions as an evidence base for decision makers charged with maximising health gains from available resources. This paper critically appraises the information...
Persistent link: https://www.econbiz.de/10005404817
The National Institute for Clinical Excellence (NICE) responds to requests by the Department of Health for guidance on the use of selected new and established technologies in the National Health Service (NHS) in England and Wales. This paper asks whether the NICE methodological guidelines help...
Persistent link: https://www.econbiz.de/10004990353
Various methods have been proposed to address uncertainty in economic evaluations of healthcare programmes. One approach suggested in the literature is to estimate separate confidence intervals for the incremental costs and effects of a new health programme in comparison with an existing...
Persistent link: https://www.econbiz.de/10005449113
Persistent link: https://www.econbiz.de/10005243128
Persistent link: https://www.econbiz.de/10005243160
Objective: To compare the expected costs and outcomes of alternative strategies for the management of patients with erosive oesophagitis. Design: There were 3 components to the overall analytic approach. First, a decision model was constructed to compare expected costs and outcomes of 6...
Persistent link: https://www.econbiz.de/10005590331
Cost-effectiveness acceptability curves (CEACs) are a method used to present uncertainty surrounding incremental cost-effectiveness ratios (ICERs). Construction of the curves relies on the assumption that the willingness to pay (WTP) for health gain is identical to the willingness to accept...
Persistent link: https://www.econbiz.de/10005243158
In Canada, there are two separate review processes for the public reimbursement of drugs: one for cancer drugs (originally called the Joint Oncology Drug Review [JODR] and now called the pan-Canadian Oncology Drug Review [pCODR]) and one for drugs in all other disease areas (called the Common...
Persistent link: https://www.econbiz.de/10011241582
Despite renewed enthusiasm for the use of willingness to pay (WTP) in healthcare applications, there are still a lot of objections, resentment and scepticism regarding the desirability and feasibility of this technique. Objections can be classified into different categories: e.g. theoretical,...
Persistent link: https://www.econbiz.de/10005449276
Objective: The objectives of this study were 1. to develop a conceptual framework for selecting hospitals for unit cost estimates in national and international multicentre trials and 2. to test the impact of alternative hospital selection on the cost results. Design and setting: Within the...
Persistent link: https://www.econbiz.de/10005449283